These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16258214)

  • 21. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
    Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
    Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma.
    Maia DM; Kell DL; Goates JJ; Warnke RA
    Am J Clin Pathol; 1997 Jun; 107(6):643-52. PubMed ID: 9169660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
    Buxbaum J
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation.
    Firkin F; Hill PA; Dwyer K; Gock H
    Am J Kidney Dis; 2004 Sep; 44(3):551-5. PubMed ID: 15332228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.
    Sezer O; Schmid P; Shweigert M; Heider U; Eucker J; Harder H; Sinha P; Radtke H; Possinger K
    Bone Marrow Transplant; 1999 May; 23(9):967-9. PubMed ID: 10338056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis].
    Katayama Y; Sakai A; Nobuyoshi M; Shimomura T; Kimura A
    Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal gammopathy of renal significance with heavy-chain deposition disease in renal allograft: challenges in the diagnosis and management.
    Singh L; Subbiah AK; Singh G; Bagchi S; Dinda AK; Agarwal SK
    Transpl Int; 2019 Jul; 32(7):769-770. PubMed ID: 31081947
    [No Abstract]   [Full Text] [Related]  

  • 31. [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
    Cohen C; Javaugue V; Joly F; Arnulf B; Fermand JP; Jaccard A; Sirac C; Knebelmann B; Bridoux F; Touchard G
    Nephrol Ther; 2016 Jun; 12(3):131-9. PubMed ID: 27117766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
    Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
    Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
    Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG heavy-chain deposition disease.
    Katz A; Zent R; Bargman JM
    Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Okuda M; Nomura J; Tateno H; Kameoka J; Sasaki T
    Intern Med; 2002 Sep; 41(9):734-7. PubMed ID: 12322803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin light chain amyloidosis and the kidney.
    Gertz MA; Lacy MQ; Dispenzieri A
    Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 66-year-old woman with progressive renal insufficiency, nephrotic syndrome, and monoclonal protein.
    Chang IJ; Cheunsuchon B; Miller FJ; Fogo AB
    Am J Kidney Dis; 2003 Feb; 41(2):508-17. PubMed ID: 12552518
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kidney involvement in Idiopathic Light Chain disease. Report of one case].
    Trimarchi H; Lombi F; Forrester M; Pomeranz V; Rabinovich O; Stemmelin GR; Ruiz PA; Iotti A; Young P
    Rev Med Chil; 2013 Mar; 141(3):396-401. PubMed ID: 23900334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.